Recurrent Childhood Soft Tissue Sarcoma Completed Phase 1 Trials for Pazopanib (DB06589)

IndicationStatusPhase
DBCOND0029296 (Recurrent Childhood Soft Tissue Sarcoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00929903Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to TreatmentTreatment